Thalassemia in Viet Nam by Prof.Nguyen Anh Tri MD Ph.D Director - National institute of Hematology and Blood Transfusion President – Viet Nam Thalassemia Association
1. Thalassemia is a major health issue in Indonesia due to its large population and ethnic diversity which results in a high frequency of thalassemia mutations.
2. The government has begun pilot prevention programs and provides some financial support for diagnosis and treatment, but challenges remain due to limited resources and the country's demographics.
3. Non-government organizations and health professionals are working to increase awareness and screening, but many affected individuals still go undiagnosed or do not receive adequate care due to the costs and complexities of managing the disease.
Organ donation ethics and law Y5 UCL Medical School 2013Laura-Jane Smith
Lecture delivered in first week of Year 5 UCL Medical School. Lots of discussion and debate, particularly about the arguments for and against an opt-out system. Engaged students make teaching really fun.
Road to a Transplant: A glimpse at the organ transplantation processamylcarey
A brief look at the organ transplantation process. Inspired by Brian Primack, a heart transplant patient with Massachusetts General Hospital, Boston, MA. Listed with UNOS, Nov 2011.
1. Thalassemia is a major health issue in Indonesia due to its large population and ethnic diversity which results in a high frequency of thalassemia mutations.
2. The government has begun pilot prevention programs and provides some financial support for diagnosis and treatment, but challenges remain due to limited resources and the country's demographics.
3. Non-government organizations and health professionals are working to increase awareness and screening, but many affected individuals still go undiagnosed or do not receive adequate care due to the costs and complexities of managing the disease.
Organ donation ethics and law Y5 UCL Medical School 2013Laura-Jane Smith
Lecture delivered in first week of Year 5 UCL Medical School. Lots of discussion and debate, particularly about the arguments for and against an opt-out system. Engaged students make teaching really fun.
Road to a Transplant: A glimpse at the organ transplantation processamylcarey
A brief look at the organ transplantation process. Inspired by Brian Primack, a heart transplant patient with Massachusetts General Hospital, Boston, MA. Listed with UNOS, Nov 2011.
MRI-based Monitoring Tools for Iron Chelation by Pairash Saiviroonporn, Ph.D., Radiology Department, Faculty of Medicine Siriraj Hospital, Mahidol University
Thalassaemia is present among Australia's ethnically diverse population. There is no national registry or standardized antenatal screening policy. Estimates indicate around 326 patients with beta thalassaemia major nationally, though numbers may be higher without a registry. Diagnostic testing and genetic counseling are available through specialist centers and hospital laboratories nationwide.
Genotypes/phenotypes Thalassemia in Asia - by Suthat Fucharoen MD of the Thalassemia Research Center Institute of Molecular Biosciences, Mahidol University, Thailand.
This curriculum vitae summarizes the education and experience of James E. Nelson. He received a PhD in Molecular Biology and Genetics from Wayne State University in 1994. Since then, he has held several research and staff positions, primarily focused on nonalcoholic steatohepatitis (NASH). He has received over $5 million in grant funding and authored over 50 publications. He has also designed and conducted numerous clinical studies on NASH through the NASH Clinical Research Network.
Liver Iron Measurement by Magnetic Susceptometry alferedo
This document discusses magnetic susceptometry for measuring liver iron concentration. It describes how magnetic susceptometry works by measuring the induced paramagnetic response of iron in the liver to an external magnetic field. It discusses modeling of the human torso, including using a water bag to cancel out background tissue signals. Different types of magnetizing fields and pickup coil configurations are presented for localized measurement of liver iron.
MRI uses strong magnetic fields and radio waves to generate images of the inside of the body. It is a medical imaging technique widely used in radiology to visualize anatomy and physiological processes. MRI has many medical uses and applications across different body systems. It is generally a safe technique but there are some risks needing consideration for things like implants, projectile effects, and claustrophobia. Guidelines and certifications aim to standardize roles and ensure safe MRI practices.
Liver biopsy is currently the reference standard for assessing liver fibrosis but it has disadvantages like being an invasive procedure that carries risk. Non-invasive alternatives to biopsy include clinical indices, imaging, serum biomarkers, and measurements of liver stiffness and portal pressure. While these alternatives are safer than biopsy, they each only assess one aspect of liver disease and cannot provide the full histological assessment of biopsy. However, within defined clinical contexts, noninvasive assessment can be an attractive alternative and contribute valuable information to patient management and treatment outcomes.
CURRENT SITUATION IN CONTROL STRATEGIES & HEALTH SYSTEMS IN ASIA - CAMBODIA by PRAK PISETH RAINGSEY, MD, DND, MPH Director Preventive Medicine Department MINISTRY OF HEALTH
Understanding the molecular mechanisms leading to reactivation or derepression of γ-globin gene by Jim Vadolas, Cell and Gene Therapy Group, Murdoch Childrens Research Institute, Royal Children’s Hospital
MRI is useful for evaluating various liver conditions. It is superior to CT for detecting small liver lesions and characterizing lesions. MRI can identify diffuse liver diseases affecting hepatocytes or reticuloendothelial cells, causing homogeneous or segmental changes. Cirrhosis appears as numerous low signal regenerative nodules on T2-weighted images. Hemangiomas are intensely hyperintense on T2-weighted images and enhance peripherally on contrast images. Dysplastic nodules are generally hypointense on T1-weighted images and do not enhance with contrast. MRI utilizes multiple sequences and techniques to comprehensively evaluate liver tumors, diffuse diseases, and incidental findings.
This document discusses the multi-disciplinary care needs for patients with thalassaemia. Thalassaemia affects multiple organ systems over time as it progresses from a chronic anemia disease to one that impacts the heart, liver, endocrine system and more. It requires monitoring and treatment from specialists in cardiology, hepatology, endocrinology and others. The optimal approach is for patients to receive care at dedicated thalassaemia centers with a multi-disciplinary team that can coordinate treatment across specialties and properly manage the many complications that can arise for patients with this condition.
Current Care of Thalassaemia Major Patients in Hong Kong, China by Vincent Lee, Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong
Nurses play a critical role in any team of healthcare professionals involved in the care of patients with chronic diseases, including Hb disorders such as thalassaemia
and sickle dell disease. These are extremely challenging diseases that are fatal if left untreated.
However, by sharing expert knowledge on their prevention and treatment, these conditions can be effectively managed.
TIF places great importance on nursing as a valued part of patient care well beyond the medical component. We hope that this Guide will help and motivate more nurses across
the world to become involved in the care of patients with this group of diseases.
MRI-based Monitoring Tools for Iron Chelation by Pairash Saiviroonporn, Ph.D., Radiology Department, Faculty of Medicine Siriraj Hospital, Mahidol University
Thalassaemia is present among Australia's ethnically diverse population. There is no national registry or standardized antenatal screening policy. Estimates indicate around 326 patients with beta thalassaemia major nationally, though numbers may be higher without a registry. Diagnostic testing and genetic counseling are available through specialist centers and hospital laboratories nationwide.
Genotypes/phenotypes Thalassemia in Asia - by Suthat Fucharoen MD of the Thalassemia Research Center Institute of Molecular Biosciences, Mahidol University, Thailand.
This curriculum vitae summarizes the education and experience of James E. Nelson. He received a PhD in Molecular Biology and Genetics from Wayne State University in 1994. Since then, he has held several research and staff positions, primarily focused on nonalcoholic steatohepatitis (NASH). He has received over $5 million in grant funding and authored over 50 publications. He has also designed and conducted numerous clinical studies on NASH through the NASH Clinical Research Network.
Liver Iron Measurement by Magnetic Susceptometry alferedo
This document discusses magnetic susceptometry for measuring liver iron concentration. It describes how magnetic susceptometry works by measuring the induced paramagnetic response of iron in the liver to an external magnetic field. It discusses modeling of the human torso, including using a water bag to cancel out background tissue signals. Different types of magnetizing fields and pickup coil configurations are presented for localized measurement of liver iron.
MRI uses strong magnetic fields and radio waves to generate images of the inside of the body. It is a medical imaging technique widely used in radiology to visualize anatomy and physiological processes. MRI has many medical uses and applications across different body systems. It is generally a safe technique but there are some risks needing consideration for things like implants, projectile effects, and claustrophobia. Guidelines and certifications aim to standardize roles and ensure safe MRI practices.
Liver biopsy is currently the reference standard for assessing liver fibrosis but it has disadvantages like being an invasive procedure that carries risk. Non-invasive alternatives to biopsy include clinical indices, imaging, serum biomarkers, and measurements of liver stiffness and portal pressure. While these alternatives are safer than biopsy, they each only assess one aspect of liver disease and cannot provide the full histological assessment of biopsy. However, within defined clinical contexts, noninvasive assessment can be an attractive alternative and contribute valuable information to patient management and treatment outcomes.
CURRENT SITUATION IN CONTROL STRATEGIES & HEALTH SYSTEMS IN ASIA - CAMBODIA by PRAK PISETH RAINGSEY, MD, DND, MPH Director Preventive Medicine Department MINISTRY OF HEALTH
Understanding the molecular mechanisms leading to reactivation or derepression of γ-globin gene by Jim Vadolas, Cell and Gene Therapy Group, Murdoch Childrens Research Institute, Royal Children’s Hospital
MRI is useful for evaluating various liver conditions. It is superior to CT for detecting small liver lesions and characterizing lesions. MRI can identify diffuse liver diseases affecting hepatocytes or reticuloendothelial cells, causing homogeneous or segmental changes. Cirrhosis appears as numerous low signal regenerative nodules on T2-weighted images. Hemangiomas are intensely hyperintense on T2-weighted images and enhance peripherally on contrast images. Dysplastic nodules are generally hypointense on T1-weighted images and do not enhance with contrast. MRI utilizes multiple sequences and techniques to comprehensively evaluate liver tumors, diffuse diseases, and incidental findings.
This document discusses the multi-disciplinary care needs for patients with thalassaemia. Thalassaemia affects multiple organ systems over time as it progresses from a chronic anemia disease to one that impacts the heart, liver, endocrine system and more. It requires monitoring and treatment from specialists in cardiology, hepatology, endocrinology and others. The optimal approach is for patients to receive care at dedicated thalassaemia centers with a multi-disciplinary team that can coordinate treatment across specialties and properly manage the many complications that can arise for patients with this condition.
Current Care of Thalassaemia Major Patients in Hong Kong, China by Vincent Lee, Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong
Nurses play a critical role in any team of healthcare professionals involved in the care of patients with chronic diseases, including Hb disorders such as thalassaemia
and sickle dell disease. These are extremely challenging diseases that are fatal if left untreated.
However, by sharing expert knowledge on their prevention and treatment, these conditions can be effectively managed.
TIF places great importance on nursing as a valued part of patient care well beyond the medical component. We hope that this Guide will help and motivate more nurses across
the world to become involved in the care of patients with this group of diseases.
The ‘Basic Recommendations in Brief for Treating Physicians’, based on and complementing the ‘Guidelines for the Management of Transfusion Dependent Thalassaemia (4th Edition – 2021)’, is an easy-to-understand, user-friendly resource for thalassaemia-treating clinicians, especially for those who are not fully experienced and well-knowledgeable of the management of patients with this serious chronic disorder, or those operating in Urgent and Emergency Care (UEC) settings admitting haemoglobinopathy patients.
These key recommendations offer valuable guidance on a variety of thematics pertaining to thalassaemia management, ranging from blood transfusion and iron overload and chelation to the assessment of cardiovascular and liver disease, pregnancy management, and much more.
Provision of ideal transfusion support – The essence of thalassemia careApollo Hospitals
Thalassemia major is a major cause of transfusion dependence among patients world over. Provision of an adequate, uninterrupted and safe blood supply for these patients is the responsibility of the blood services as well as the society as a whole. Thalassemia management has evolved over a period of time and so have transfusion services. Various technological advancements have been introduced in the last few decades in order to enhance blood safety. Adoption of these newer technologies coupled with increasing awareness about voluntary blood donation in the general population can go a long way in improving the life expectancy as well the quality of life in these children.
Hemovigilance is a surveillance system that monitors the entire transfusion process from blood donation to follow-up of recipients. The National Hemovigilance Program of India (HvPI) was launched in 2012 to monitor adverse events associated with blood transfusions. HvPI collects data from over 200 medical centers using a software system. Data is analyzed at the national coordinating center to identify trends, make recommendations to improve safety, and prevent future adverse events from occurring. Reporting of all adverse events aims to advance patient safety.
This document discusses genetic blood disorders like thalassemia and sickle cell anemia in West Bengal, India. It provides statistics on carrier detection rates from screening programs from 2011-2022, finding over 200,000 carriers and 31,000 patients. It describes the conditions, effects of transfusions, and methods for prenatal diagnosis including amniocentesis, chorionic villus sampling, and preimplantation genetic diagnosis to detect disorders before or during pregnancy. Public education and training of health workers is needed to increase screening and provide counseling to carriers.
By providing a short pocket guide describing the best possible practices in the treatment and management of transfusion-dependent thalassaemia (TDT), TIF seeks to support physicians worldwide in making good clinical decisions that can benefit individual patients with the disorder and enable them to advocate for more and better resources for thalassaemia care at the level of national health authorities.
The 4th edition of the original full-length Guidelines, published in June 2022, includes a full review of the evidence supporting almost each recommendation for physicians to know all the facts that form the basis of their clinical decisions in the form of a long textbook, difficult to use on a daily basis.
Nursing Case study paroxysmal nocturnal hemoglobinuriapinoy nurze
The document provides information on Paroxysmal Nocturnal Hemoglobinuria (PNH), including:
1) PNH is a rare disease that affects red blood cells, causing their breakdown and release of hemoglobin in the urine.
2) It occurs most commonly in young adults and presents with dark colored urine, fatigue, and pain.
3) Treatment focuses on blood transfusions, anticoagulation medications, antibiotics, and corticosteroids. A bone marrow transplant may potentially cure PNH.
Innovative twinning programme in prison settingVih.org
Access to HIV prevention and care in prisons of Cote d'Ivoire. ESTHER intiative in MACA prison.
Une présentation d'Arnaud Laurent, à l'occasion de la conférence internationale sur le sida de Vienne 2010.
Prevalence of Anamiea and Its Predictors in Pregnant Women Attending Antenata...iosrjce
Background: Anemia impairs cognitive development, reduces physical work capacity and in severe cases
increases risk of mortality particularly during prenatal period. In India, 16% of maternal deaths are attributed
to anemia. However, high prevalence of anemia among pregnant women persists in India despite the
availability of effective, low-cost interventions for prevention and treatment. Aknowledge of them
sociodemographic factors associated with anemia will help to formulate multipronged strategies to attack this
important public health problem in pregnancy.
Objective: To assess the prevalence of anaemia and its predicting factors among pregnant women attending
antenatal clinic at Tertiary care center.
Study Design: Descriptive cross-sectional study
Methods: A hospital based cross-sectional study design was conducted from January 2014 – September 2014
among 5788 pregnant womens who had been attending antenatal clinic. Red blood cell morphology and Hgb
level determination were assessed following the standard procedures. Socio-demographic data was collected by
using a structured questionnaire. The data entered and analyzed by using the SPSS version 16.0 statistical
software. P<0.05 was considered as statistically significant.
Result: Overall prevalence of anemia among the pregnant women was found to be 86.37%. Factors such as
diet, level of education of women and their husbands and socioeconomic status were found to be significantly
associated with the prevalence of anemia in pregnancy.
Conclusion: The present study showed high prevalence of anemia and the majority of them were of the
moderate type (hemoglobin: 10-10.9 g/dl). Low socioeconomic class, illiteracy, Multiparous were significantly
associated with high prevalence of anemia during pregnancy in Indian women.
Thalassemia in Laos: Situation Analysis by Dr. Sourideth Sengchanh, Dr. Alongkone Phengsavanh, Assoc. Prof. Dr. Khampe Phongsavat, University of Health Sciences, Vientiane, Laos. Presented by Assoc. Prof. Dr. Khampe Phongsavat.
- South Africa's antiretroviral (ARV) treatment program is the largest in the world, providing treatment to over 1 million people by 2010, though total need is estimated at 5.7 million.
- The program faces challenges of expanding capacity to treat the additional 300,000 people in need each year given constraints of human resources, infrastructure, and drug supply.
- Recent government efforts to address gaps include increasing the health budget, expanding treatment guidelines in line with WHO recommendations, implementing task shifting, and centralized drug purchasing to reduce costs.
Italy has a well-established national system for screening, diagnosis, and treatment of haemoglobinopathies like thalassemia and sickle cell disease (SCD). There are over 130 clinical centers and 20 molecular diagnostic laboratories. In 2010, over 7,000 patients were followed, including over 4,000 with thalassemia major and over 1,300 with SCD. National guidelines are developed by the Italian Society of Thalassemias and Haemoglobinopathies. Regional registries collect clinical data and the National Institute of Health maintains a national registry. Some treatment options like chelation therapy and genetic counseling are available. Further research collaborations and funding are recommended to continue progress.
National Thalassaemia Screening Program , MalaysiaHCY 7102
This document outlines Malaysia's National Thalassemia Screening Program. The objectives are to identify carriers of thalassemia to assess risk of affected children and provide information on options. Strategies include strengthening cascade screening of families of known cases and carriers, and targeted screening of adolescents and young adults, especially before marriage. Screening will take place in schools and camps on a voluntary basis and genetic counseling will be provided to carriers to educate them on risks and options. The goal is to reduce new cases of blood transfusion dependent thalassemia through prevention and control efforts.
1. This document discusses Hepatitis B, including its causes, transmission, prevalence in Yemen, clinical features, diagnosis, and prevention.
2. Yemen has an intermediate prevalence of Hepatitis B, between 2-7% of the population, with mortality from viral hepatitis being 22% of deaths.
3. The disease is caused by the Hepatitis B virus and transmitted through blood or bodily fluids. It can range from acute to chronic infection leading to cirrhosis or liver cancer. Prevention focuses on vaccination, sterilization of medical equipment, and screening blood donors.
An educational leaflet aiming to strengthen the knowledge and understanding of patients with thalassaemia and other haemoglobin disorders across the world on most aspects relevant to gene therapy.
This document discusses discharge planning for patients leaving the hospital. It explains that discharge planning aims to improve coordination of post-hospital care by considering a patient's needs. It seeks to connect hospital care with post-hospital care, reduce hospital length of stay, and minimize unplanned readmissions. The process of discharge planning can vary and is not always evidence-based. Effective discharge planning provides continuity of care and involves health professionals, family, social services, and the patient.
The document discusses guidelines from the 2015 ESC on the diagnosis and management of pericardial diseases. It provides an overview of key sections and recommendations from the guidelines. The sections discussed include epidemiology of pericardial diseases, aetiology of pericardial diseases, acute pericarditis, and recurrent pericarditis. It emphasizes the need to gather more specific epidemiological data from different geographical areas to better understand differing aetiologies. It also notes that the most frequent cause of pericarditis (idiopathy) is not fully understood and warrants further examination.
The Solomon Islands HiT determines that the country’s health system has significant weaknesses but also considerable strengths. Despite the range and difficulty of issues facing policy-makers in the Solomon Islands, there have been significant achievements in health, including considerable progress in advancing population health status. The performance of the health system is positive, achieving high coverage, high satisfaction levels, and steady progress on health outcomes. Nonetheless, the country faces important health challenges that could undermine development gains made to date
Similar to Viet Nam - Current Situation in Control Strategies and Health Systems in Asia (20)
Bone marrow transplantation for thalassemia in lower resource settings - The Cure2Children Foundation experience in Pakistan. By Dr Naila Yaqub, Assistant Professor, Bone Marrow Transplant unit, The Children hospital, PIMS, Pakistan
Gene therapy aims to cure β-thalassemias by using lentiviral vectors to insert functional β-globin genes into hematopoietic stem cells. The first patient treated achieved long-term transfusion independence with stable multi-year expression of the corrected globin. Analysis found most genetically modified cells contained the vector integrated near the HMGA2 gene, though the majority of cells remained unmodified. Ongoing work continues to optimize the therapy.
Treatment of patients with β-Thalassaemias focuses on improving outcomes through regular blood transfusions and iron chelation therapy to remove excess iron from previous transfusions. Advances in transfusion and chelation regimens have led to significantly improved survival rates over time. Maintaining low levels of iron overload through adherence to chelation therapy and monitoring of iron levels correlates strongly with reduced complications and improved long-term survival and outcomes for patients with thalassaemia major.
Genetic Screening and Prenatal Diagnosis of Thalassemias and Hemoglobinopathies in Taiwan Today by Ching-Tien Peng, MD, MPH, Superintendent & Prof. of The Children’s Hospital, China Medical University & Hospitals, Prof. of Biotechnology, Asia University, Taichung, Taiwan
Taiwan has a population of over 23 million people with a GDP per capita of $18,603. The country implemented a National Health Insurance program in 1995 that provides coverage for inpatient, outpatient, and limited home care. Thalassemia is prevalent in Taiwan, with carrier rates of 5-8% for various types. The country has a national prevention program that screens pregnant women and provides confirmatory testing and genetic counseling. Treatment for thalassemia major includes regular blood transfusions paid for by National Health Insurance as well as iron chelation therapy. Multidisciplinary expert centers provide coordinated care and management for patients.
Current Situation in Control Strategies and Health Systems in Philippines by ERNESTO d’J. YUSON MD, Thalassemia Center of the Philippines, Balikatang Thalassaemia
Thalassaemia in Bangladesh by Dr. Waqar Ahmed Khan, MBBS, M.Phil who is Professor of Pathology, Bangladesh Institute of Child Health, Dhaka Shishu (Children) Hospital and President of Dhaka Shishu Hospital Thalassaemia, Dhaka, Bangladesh.
Current Situation in Control Strategies and Health Systems in Myanmar, Asia by PROFESSOR DR. NE WIN, DIRECTOR (LABORATORY AND BLOOD SERVICE), MINISTRY OF HEALTH, UNION OF MYANMAR
Current Situation in Control Strategies and Health Systems in Asia - Sri Lanka by Rasnayaka M Mudiyanse, Senior Lecturer in Paediatrics at the University of Peradeniya and Consultant Paediatrician at the Teaching Hospital in Peradeniya.
Current Situation in Control Strategies and Health Systems in Asia - India by Roshan B.Colah, Scientist F- Deputy Director (SG), National Institute of Immunohaematology, Parel, Mumbai
Current Situation in Control Strategies and Health Systems in Asia by Prof. Dr. Jovaria Mannan, Professor of Paediatrics, Chairperson of the Medical Advisory Board, Thalassaemia Federation of Pakistan
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Viet Nam - Current Situation in Control Strategies and Health Systems in Asia
1. THALASSEMIA IN VIET NAM
Prof.Nguyen
Prof Nguyen Anh Tri M D Ph D
Tri, M.D, Ph.D
Director - National institute of Hematology and Blood Transfusion
President – Viet Nam Thalassemia Association
1
2. Geographic
- Land area: 331.698 km2
- Population: 85.847 million (2009)
Estimated:
E ti t d 87 million (
illi (now)
)
- Life expectancy: 72,8 years
-The birth rate (2010): 1,64%
- New born babies: 1.4 million/year
- Ethnicity: 54 ethnic groups
Kinh: 85%
- Religions: Buddhist: 85%
2
3. Geographic
GDP(2010): about 104.6 billion USD
Per capital income about $ 1.200 in 2010
The budget expenditures for the health sector:
In 2011: 43 200 billion accounting for 5 95% of
43,200 billion, accounting for 5.95% of
total national budget
approximately U.S. $ 25 per person
4. Health system
Public system: four main routes:
(1) central (3) County/District
(2) provincial/city (4) village (local level)
Three main fields: research, treatment and prevention
, p
in institutes or leading hospitals at central level.
Private li i
P i t clinic: some of specialties
f i lti
big cities .
4
5. Epidemiology
- Thalassemia carrier:
- Alpha thalassemia: 1,7%-25%, ~ 2,1% for average.
- βthal and βthal/HbE: 0,7% - 20%, ~ 1,4% for average.
- HbE gene: 1,7% - 41 %, ~ 2,6% for average.
- High rate in minority and mountain
g y
- Estimated 5,3 million people carry the disease congenital hemolytic
~ 2,400new births with thal disease amongs 1.4 million new
born babies every year, include 430 βthal, 520 βthal/HbE, 1050
yy , β , β ,
HbH and 435 Hb Bart
5
6. Management
Thalassemia has been concerned by state and society:
The screening programme and counselling that
in six districts of Hoa Binh province (Dr Truc’s presentation)
Viet Nam Thalassemia association (ViTA) was established
in February 2011.
E t bli h
Establishment of th l
t f thalassemia t t
i treatment unit
t it
Many studies have implemented since 1960s
Thalassemia is in the list of diseases which are covered by
Health Insurance
Insurance.
6
9. Diagnosis and treatment
Diagnosis
Formula peripheral blood cells: all hospitals
Hemoglobin electrophoresis: some of provincial, all central
hospitals
Define Thalassemia gene in some hospitals
Prenatal diagnosis fetal diagnosis: Children's Central Hospital,
diagnosis, Children s Hospital
Tu Du Hospital.
Treatment
Blood transfusion: in the district provincial and central hospitals
district,
Iron chelating: Central Hospitals
Stem Cell Transplantation
9
10. Diagnosis and treatment
Blood and blood products
Two forms of blood donation: Voluntary unpaid(84.2%), paid (15.8%).
y p ( ), p ( )
Voluntary unpaid is 92% at NIHBT
Each unit of 250 ml is about US $ 23.
Health insurance pay 100%, 95% or 80% (depending on the types)
Vietnam is moving toward implementation of the popularization of health
insurance
Blood for Thal patients
Frequency of blood transfusions for major and intermedia: once a month
(many patients could not go to the hospital for blood transfusion
because of their own situation)
Hemoglobin concentrations achieved after transfusion: 100g/l.
10
11. Diagnosis and treatment
Iron chelators
Desferrioxamine and Deferiprone: available since 1996
To be used only in large central hospitals
Desferrioxamine is commonly used for all hospitalized
patients, Desferiprone was issued to outpatients
The medicine is covered by health insurance
11
12. ACTION PLAN
1. Building national Thalassemia programs
2. Establishing Thalassemia center in Hanoi, then deploy
branches in the provinces
3. Screening and preventing programs in Hoa Binh
province and the others
4. Providing training for health staffs at the provincial
hospitals
12
13. ACTION PLAN
5. Improving the quality of diagnosis
Develop diagnostic and treatment protocol uniformly across
the country
Deploying do hemoglobin electrophoresis in all provincial
hospitals
Thalassemia genetic testing in the central hospitals
Doing prenatal diagnosis in more hospitals
13
14. ACTION PLAN
6. Improving the quality of treatment
Bl d t
Blood transfusion: t i t provide enough bl d f Th l
f i trying to id h blood for Thal
patients
Perform phenotype blood transfusion for patients with red
cell antibody
ll tib d
Iron chelating: put iron chelators into the list of essential
medicines at the provincial hospitals
Stem cell transplantation for patients with major beta
thalassemia
14
15. ACTION PLAN
7. Strengthening activities of ViTA
Publication
Training for active members
Education for patients/family members
Step
St up operations t raise f di
ti to i funding
Propagate to community,
Marriage consulting is first priority.
8. Desiring to be twinned with other Thalassemia centers and
Thalassemia associations in the world.
15